Chinese activists protest the use of traditional treatments - they want medical science

In the West, the number of people challenging scientific authority has been growing in past decades. This has, among other things, led to a decline in the support for mass vaccination programmes and to an increase in alternative forms of treatment. In China, however, activists are defending modern medical science and criticising Traditional Chinese Medicine, which hospitals are obliged to offer to patients on an equal footing with modern medical care.

Over a number of years, Chinese researcher Qiaoyan Zhu, who has been affiliated with the University of Copenhagen's Department of Communication, has collected data on the many thousand science activists in China through observations in Internet forums, on social media and during physical meetings. She has also interviewed hundreds of activists.

Together with Professor Maja Horst, who has specialised in research communication, Zhu has analysed the many data on the activists and their protests in an article that has just been published in the journal Public Understanding of Science:

"The activists are better educated and wealthier than the average Chinese population, and a large majority of them keep up-to-date with scientific developments. The protests do not reflect a broad popular movement, but the activists make an impact with their communication at several different levels," Maja Horst explained and added:

"Many of them are protesting individually by writing directly to family, friends and colleagues who have been treated with - and in some cases taken ill from - Traditional Chinese Medicine. Some have also hung posters in hospitals and other official institutions to draw attention to the dangers of traditional treatments. But most of the activism takes place online, on social media and blogs.

The activists hold the cards

Activists operating in a regime like the Chinese are obviously not given the same leeway as activists in an open democratic society - there are limits to what the authorities are willing to accept in the public sphere in particular. However, there is still ample opportunity to organise and plan actions online.

"In addition to smaller groups and individual activists that have profiles on social media, larger online groups are also being formed, in some cases gaining a high degree of visibility. The card game with 52 criticisms about Traditional Chinese Medicine that a group of activists produced in 37,000 copies and distributed to family, friends and local poker clubs is a good example. Poker is a highly popular pastime in rural China so the critical deck of cards is a creative way of reaching a large audience," Maja Horst said.

Maja Horst and Qiaoyan Zhu have also found examples of more direct action methods, where local activist groups contact school authorities to complain that traditional Chinese medicine is part of the syllabus in schools. Or that activists help patients refuse treatment if they are offered treatment with Traditional Chinese Medicine.

Will we see similar science activism in Europe?

The Chinese style of science activism, which Maja Horst and Qiaoyan Zhu have studied, is rather traditional and fact-based compared to the often more spectacular and symbol-laden communication that Western activists use when, for example, protesting genetic research. But they conclude by anticipating a possible similar development in the West:

"We have already seen Marches for Science in the US and Europe so it is not unlikely we will begin to see more activism in favour of science and evidence-based medicine in our part of the world as well. We may well see a counter-reaction towards climate sceptics and anti-vaxxers who challenge established science and its results."

Qiaoyan Zhu, Maja Horst.
Science communication activism: Protesting Traditional Chinese Medicine in China.
Public Understanding of Science, Volume: 28 issue: 7, page(s): 812-827. doi: 10.1177%2F0963662519865405.

Most Popular Now

Novartis announces plan to initiate clinical trial…

Novartis today announced plans to initiate a Phase III clinical trial to study canakinumab in patients with COVID-19 pneumonia. The CAN-COVID trial will examine the effic...

Gilead announces results from Phase 3 trial of inv…

Gilead Sciences, Inc. (Nasdaq: GILD) announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and 10-day dosing durations of the investigation...

AstraZeneca and Oxford University announce landmar…

AstraZeneca and the University of Oxford announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine a...

Sanofi and Regeneron provide update on U.S. Phase …

Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the preliminary results from the Phase 2 portion of an ongoing Phase 2/3 trial evaluating Kevzar...

Roche's COVID-19 antibody test receives FDA Emerge…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) (1) for its new Elecsys® Ant...

Pfizer and BioNTech dose first participants in the…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 va...

Arthritis drug may improve respiratory function in…

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients ...

Early indicators of vaccine efficacy

Ludwig-Maximilians-Universität (LMU) in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of...

Frankfurt researchers discover potential targets f…

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-...

Vitamin D linked to low virus death rate

A new study has found an association between low average levels of vitamin D and high numbers of COVID-19 cases and mortality rates across 20 European countries. The r...

Loss of smell associated with milder clinical cour…

Following an earlier study that validated the loss of smell and taste as indicators of SARS-CoV-2 infection, researchers at UC San Diego Health report in newly published ...

Can an existing HIV medication slow the spread of …

A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug...